Evidence Intelligence™
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 83
- Positive
- ConsistencyScore™
- 67
- generally_consistent
Estudios de apoyo: Basado en 6 estudios
Add to Evidence TrackerResumen de Investigación
Analyzed using Evidence Intelligence™
Omnipod DASH Improves Treatment Satisfaction in Type 1 Diabetes
Última actualización 29 de agosto de 2026
Key finding
ΔDTQ-current score of 16.4 [21.2] vs 0.0 [12.8]; P < .001
This study compared treatment satisfaction between the Omnipod DASH Insulin Management System and Usual Care in adults with Type 1 Diabetes, finding significant improvements with the Omnipod.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This study compared treatment satisfaction between the Omnipod DASH Insulin Management System and Usual Care in adults with Type 1 Diabetes, finding significant improvements with the Omnipod.
Clinical relevance
Improving treatment satisfaction and glycemic control is crucial for individuals with Type 1 Diabetes, as it can lead to better adherence to treatment and overall health outcomes. The Omnipod DASH system may offer a more effective and user-friendly alternative to traditional insulin delivery methods.
Keep in mind
The study may have limited generalizability due to its specific population. Potential biases in self-reported measures of satisfaction. Short duration of follow-up may not capture long-term effects.
Published in
Referencia de la Revista
Publication details and source links for this paper.
Yee WK, Cheng YY, Katerina K, et al. Treatment Satisfaction with the Omnipod DASH Insulin Management System Compared to Usual Care in Adults with Type 1 Diabetes. The Journal of Clinical Endocrinology and Metabolism. 2024;109(8):1984-1995. doi:10.1210/clinem/dgae088
Efectos Principales
The Omnipod group showed a significant increase in Diabetes Technology Questionnaire current score by 16.4 (P < .001).
HbA1c levels decreased by -0.4% in the Omnipod group compared to -0.1% in the Usual Care group (P = 0.037).
Time in range improved significantly at the end extension for the Omnipod group (5.6% change; P = .016).
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Insulin therapy, Omnipod DASH Insulin Management System and HbA1c, Type 1 diabetes knowledge score, Time in range.
This study contributes evidence to
Primary intervention
Insulin therapy
Primary outcomes
- HbA1c
- Type 1 diabetes knowledge score
- Time in range
Evidence topics
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
5
Evidence pairs
5
Relationships
3
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 68
3
Related topics
5
Evidence pairs
845
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 5 evidence relationships
- Includes primary outcome data
- Linked to 3 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Agrega evidencia relacionada a tu Evidence Tracker
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Relación de evidencia
Insulin Therapies and HbA1c
Evidencia relacionada
Tema de evidencia
HbA1c Reduction
Guardar evidencia
Tema de evidencia
Glycemic Control
Guardar evidencia
Core evidence
Study findings
The primary outcomes reported in this study.
Type 1 diabetes knowledge score
Insulin therapy → Type 1 diabetes knowledge score
Insulin therapy → Type 1 diabetes knowledge score
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerTime in range
Omnipod DASH Insulin Management System → Time in range
Omnipod DASH Insulin Management System → Time in range
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerType 1 diabetes knowledge score
Omnipod DASH Insulin Management System → Type 1 diabetes knowledge score
Omnipod DASH Insulin Management System → Type 1 diabetes knowledge score
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
La Evidencia Sugiere
- Omnipod users reported 16.4 points higher satisfaction (P < .001).
- HbA1c decreased by -0.4% in the Omnipod group (P = 0.037).
- Time in range improved by 5.6% at extension (P = .016).
A quién se aplica
- Adults diagnosed with Type 1 Diabetes.
- Individuals currently using insulin therapy.
Tener en Cuenta
- Results may not apply to younger populations or those with Type 2 Diabetes.
- Further studies are needed to assess long-term outcomes.
- Variability in individual responses to treatment may exist.
Entre Líneas
- The study may have limited generalizability due to its specific population.
- Potential biases in self-reported measures of satisfaction.
- Short duration of follow-up may not capture long-term effects.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Insulin Therapies and HbA1c, Insulin Therapies and CGM Time in Range.
Relaciones de evidencia relacionadas
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Medications
Insulin Therapies → HbA1c
Medications
Evidence Intelligence™
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 83
- Positive
- ConsistencyScore™
- 67
- generally_consistent
Estudios de apoyo: Basado en 6 estudios
View evidenceMedications
Insulin Therapies → CGM Time in Range
Medications
Evidence Intelligence™
- EvidenceScore™
- 82
- Strong
- ImpactScore™
- 70
- Positive
- ConsistencyScore™
- 60
- generally_consistent
Estudios de apoyo: Basado en 5 estudios
View evidenceIncluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
HbA1c Evidence Hub
All studies measuring HbA1c
6 studies
outcome_hubMeasures HbA1c as a key outcome.
Insulin Therapies Evidence Hub
All studies on Insulin Therapies
6 studies
intervention_hubContributes to Insulin Therapies evidence base.
CGM Time in Range Evidence Hub
All studies measuring CGM Time in Range
5 studies
outcome_hubMeasures CGM Time in Range as a key outcome.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explora más en Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Insulin therapy and HbA1c
Intervention: Insulin therapyOutcome: HbA1c
6 results
All studies on Insulin therapy and Time in range
Intervention: Insulin therapyOutcome: Time in range
5 results
All studies on Insulin therapy
Intervention: Insulin therapy
6 results
All studies measuring HbA1c
Outcome: HbA1c
6 results
All studies measuring Time in range
Outcome: Time in range
5 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Insulin Therapies improve HbA1c?
Strong Evidence
Insulin Therapies may improve HbA1c.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 83.3 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study
Why this answer: This answer is based on 15 supporting studies with generally consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Does Omnipod DASH Insulin Management System improve HbA1c?
Emerging Evidence
Omnipod DASH Insulin Management System appears to improve HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Omnipod DASH Insulin Management System improve type 1 diabetes knowledge score?
Emerging Evidence
Omnipod DASH Insulin Management System appears to improve Type 1 diabetes knowledge score.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Type 1 diabetes knowledge score
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Insulin therapy improve type 1 diabetes knowledge score?
Emerging Evidence
Current evidence does not show a clear benefit of Insulin therapy for Type 1 diabetes knowledge score.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Type 1 diabetes knowledge score
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
Semaglutide with Insulin Improves Diabetes Control and Kidney HealthVildagliptin improves glycemic control in type 2 diabetes patients on insulinHybrid Closed-Loop Insulin Improves Glycemic Control in YouthQCC Model Enhances Diabetes ManagementArtificial pancreas may improve glucose control in type 1 diabetes
Sin anuncios. Sin rastreo.
Centrada en la evidencia, no en la publicidad.
Segura y privada
Tus datos siempre están protegidos.
Siempre al día
Se agregan nuevos estudios todos los días.